Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
The sector saw $2.9 billion worth of ad reviews in 2003-04, when people were still able to joke about side effects mentioned in ads. (Remember the four-hour erection warning from Cialis?) But this year, only $1.3 billion worth of pharma advertising was reviewed as more serious side effects of drugs came to light, and consumers complained before Congress and the FDA that DTC ads create “a culture of disease and fear.” There also appeared to be fewer blockbuster drugs going to market.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in